We are excited to announce the first member of our Brain Trust, a group of advisors and colleagues who will help PALTOWN and its communities thrive.
Dr. Tom Marsilje, Chief Scientific Advisor
Dr. Tom Marsilje is a 20-year oncology drug discovery scientist, including being a co-inventor of the non-small cell lung cancer drug “ceritinib”. He is a co-author on 25 scientific publications and is co-inventor of 19 Issued US Patents.
He is also diagnosed with “currently incurable” stage IV colorectal cancer (CRC). First diagnosed with CRC in 2012, he quickly realized that he had a unique viewpoint as both a Stage IV patient and as an oncology drug discovery scientist. He recognized that this unique dichotomy could be a powerful tool for CRC patient advocacy. He can see and articulate both viewpoints of cancer: the patient viewpoint and the scientific viewpoint. His advocacy was kicked off by being a Colon Club featured survivor in their 2016 Colondar 2.0 annual magazine, bringing national-level awareness to early-onset CRC.
Since that advocacy start, highlights include helping to create and run as lead scientist the COLONTOWN CLINICS CRC Clinical Trial online communities recently featured on NBC Evening News with Lester Holt and MSNBC and the release of a MSS-CRC curated clinical trial finder as featured by STAT News.
As a prolific writer, he writes a personal blog on life at the intersection of being both a cancer patient and researcher with regular readership in 150 countries “Adventures in Living Terminally Optimistic”, a science column for Fight Colorectal Cancer “The Currently Incurable Scientist“, and has written numerous columns on Stage IV cancer life and issues for the Philadelphia Inquirer newspaper and website.